Sano blog (27)

podcast recap population health health equity

The Genetics Podcast recap: Championing diversity and accessibility in genomics with Mavis Machirori

In the latest episode of the Genetics Podcast, Sano CEO Patrick Short had the pleasure of speaking with Mavis Machirori, a senior researcher at the Ada Lovelace...

overview of fda guidance on natural history studies - social

rare disease protocol design

Navigating FDA guidance on natural history studies

Developing treatments for rare diseases involves unique obstacles due to the rarity and complexity of these conditions. To address these challenges, the FDA off...

thought leadership patient engagement

Passion and purpose: Celebrating Clinical Trials Day at Sano

In honour of Clinical Trials Day, we're sharing some reflections from our team at Sano about why we do what we do. Clinical Trials Day marks the anniversary of ...

rare disease protocol design

Understanding disease progression: The power of natural history studies

A natural history study is a preplanned observational study designed to track the course of a disease over time. Its purpose is to identify demographic, genetic...

rare disease genetic testing

Exploring natural history studies in drug development

Natural history studies are vital for understanding disease progression, particularly in rare diseases. They provide a baseline to evaluate the effectiveness of...

precision medicine thought leadership data privacy

Legal landscapes in precision medicine: Market access and intellectual property law

Precision medicine takes into account individual differences in patients' genes, environments, and lifestyles to guide treatment and prevention. That reliance o...

patient recruitment rare disease

Key takeaways from the World Orphan Drug Congress

Last week, our team had the opportunity to attend the World Orphan Drug Congress in Boston. The event was a dynamic gathering, where leaders from biopharma, reg...

precision medicine rare disease genetic testing

Newborn genome sequencing: Benefits, risks, and ethics

Children born with rare inherited conditions often face a protracted diagnostic odyssey before the cause of their illness is identified. This delay is costly, s...

biomarkers precision medicine genetic testing

From genome to bedside: Dr. Andrea Gropman on how genetics is transforming modern medical practice

In the informative webinar hosted by Dr. Patrick Short, Co-founder and CEO of Sano Genetics, guest Dr. Andrea Gropman explored the profound impact of genetics a...

protocol design patient engagement

Patient-centric innovation: Sano's highlights from the CMO Summit 360°

Last week, Sano had the privilege of travelling to Boston for the Chief Medical Officer Summit 360°, where our Co-founder and COO, Charlotte Guzzo, shared her e...

Clinical research blog